-- Company Invests in New Production Plant -- Company Expects to Meet Its FY2008 Net Income Make Good Of $5.6 Million,
or EPS of $.18
CHENGDU, China, July 10, 2008 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc. (OTC Bulletin Board: TYNP), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has completed production for the earthquake relief on May 28 and resumed its normal production.
On May 12, 2008, an 8.0-magnitude earthquake struck in Wenchuan County, Sichuan province. By order of the Sichuan Government, Tianyin is one of the thirty-five pharmaceutical companies within Sichuan province designated to supply medicines for the relief. The Company dedicated its production of medicines for the relief from May 14 to May 28 and resumed its normal production on May 29. The provincial government purchased approximately $725,000 of medicines at full retail price from the Company which included Benorilate Granules (Arpu Shuangxin Oral Liquid), Azithromycin Dispersible Tablets, Yinqiao Shangfeng Capsules, Chuanxinlian Capsules, Qingre Jiedu Capsules and Yinhuang Capsules. Tianyin delivered all the ordered medicines on May 29 and has already received 50% of the payment from the Sichuan Government.
Recently, the management of Tianyin Pharmaceutical started its new
production plant project which will enhance its overall production capacity
by 3 times with an estimated expenditure of $5 million. The capital need
for the expansion was utilized from the recent $15.2 million financing
completed in January 2008. The planned GFA is about ten thousand square
meters with state- of-the-art equipment which will be installed.
Construction will begin in July 2008 and operations are planned to begin in
January 2009. The new capacity is expected to meet increasing market demand
of current products and support new product lau
'/>"/>
| SOURCE Tianyin Pharmaceutical, Co., Inc. Copyright©2008 PR Newswire. All rights reserved |